Blog
RSS FeedPosted by Michael Wonder on 15 Jun 2017
Providing $400,000 life-saving drug to Australian kids with rare disease
15 June 2017 - The Australian Government will provide a life-saving treatment to Australian patients who have a rare medical condition ...
Posted by Michael Wonder on 03 Jun 2017
Recommendation made by the PBAC - April 2017
2 June 2017 - PBAC publishes single outcome from out of session meeting. ...
Posted by Michael Wonder on 22 Apr 2017
Recommendations made by the PBAC - March 2017
21 April 2017 - The recommendations from the March 2017 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available. ...
Posted by Michael Wonder on 18 Mar 2017
Additional public summary documents from the November 2016 PBAC meeting
17 March 2017 - The public summary documents (first time rejections and deferrals) from the November 2016 PBAC meeting are ...
Posted by Michael Wonder on 07 Mar 2017
PBAC publishes final two outcomes from the November 2016 meeting
7 March 2017 - The outcomes for tolvaptan and trifluridine with tipiracil hydrochloride are now available. ...
Posted by Michael Wonder on 07 Feb 2017
Updated PBAC outcomes for November 2016
7 February 2017 - Subsequent to the deferral at the November 2016 PBAC meeting, the PBAC recommended the PBS listing of ...
Posted by Michael Wonder on 06 Feb 2017
Cystic fibrosis sufferers to get lifesaving medication for free after government intervention
6 February 2017 - A life changing drug — previously unaffordable for Australia’s littlest cystic fibrosis sufferers costing $300,000 a ...
Posted by Michael Wonder on 27 Jan 2017
Recommendations made by the PBAC - December 2016
27 January 2016 - The outcomes from the December 2016 PBAC meeting are now available. ...
Posted by Michael Wonder on 03 Jan 2017
2016 in review
4 January 2017 - The PBAC considered 192 submissions in 2016; 193 were considered by the Committee in 2015. ...
Posted by Michael Wonder on 18 Dec 2016
Summary of submissions and outcomes from the November 2016 PBAC meeting
19 December 2016 - 70 submissions were considered at the July 2016 PBAC meeting (this includes submissions relating to “Other ...
Posted by Michael Wonder on 21 Aug 2016
Insights from the PBAC July 2016 meeting
22 August 2016 - The publication of the outcomes from the PBAC July 2016 meeting presents another opportunity to study ...
Posted by Michael Wonder on 21 Aug 2016
Summary of the outcomes from the PBAC July 2016 meeting
19 August 2016 - The outcomes from the PBAC July 2016 meeting are now in the public domain. ...
Posted by Michael Wonder on 19 Aug 2016
HIV prevention drug Truvada won't be subsidised in Australia anytime soon
19 August 2016 - An expensive combination product that prevents people from getting HIV won't be funded by taxpayers in Australia ...
Posted by Michael Wonder on 10 Aug 2016
PBAC Drug Utilisation Sub Committee outcome statement
10 August 2016 - The outcome statement from the PBAC Drug Utilisation Sub Committee June 2016 meeting is now available. ...
Posted by Michael Wonder on 02 May 2016
Cystic fibrosis patients campaign for drug Orkambi to be listed on Pharmaceutical Benefits Scheme
2 May 2016 - Without subsidy, it costs about US $260,000 each year. ...